KNC Laboratories Co.,Ltd.
6.70
EUR
+0.16
(+2.45%)
Important Dates
KNC Laboratories Co.,Ltd.'s next confirmed earnings release is scheduled for November 13, 2026.
| Earnings Date | 11/13/2026 |
Share Statistics
As of March 31, 2026, KNC Laboratories Co.,Ltd. has 7.74M shares outstanding.
| Shares Outstanding | 7.74M |
Financial Position
As of March 31, 2026, KNC Laboratories Co.,Ltd. maintains a current ratio of 2.87, meaning it holds 2.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.87 |
| Quick Ratio | 0.80 |
| Debt / Equity | 25.54 |
Financial Efficiency
These figures cover the twelve months ended March 31, 2026.
| Employee Count | 325.75 |
Stock Price Statistics
EURThese figures are as of the close on October 22, 2026.
| 50-Day Moving Average | 6.29 |
Balance Sheet
EURAs of March 31, 2026, KNC Laboratories Co.,Ltd. holds 11.85M in cash and equivalents against 19.61M in total debt, resulting in a net debt position of 7.76M. Total book value stands at 76.76M, with working capital of 27.72M providing operational flexibility.
| Cash & Cash Equivalents | 11.85M |
| Total Debt | 19.61M |
| Net Debt | 7.76M |
| Equity (Book Value) | 76.76M |
| Book Value Per Share | 9.92 |
| Working Capital | 27.72M |